Weikaixin Kong

机构：University of Helsinki, Institute for Molecular Medicine Finland · ORCID：0000-0002-1070-7136

发表论文 41 篇 · 总被引 604 次 · h-index 13

代表论文

• Prediction of drug efficacy from transcriptional profiles with deep learning (2021 · Nature Biotechnology · 被引 195)
• Systematic review of computational methods for drug combination prediction (2022 · Computational and Structural Biotechnology Journal · 被引 66)
• Expression and Prognostic Characteristics of Ferroptosis-Related Genes in Colon Cancer (2021 · International Journal of Molecular Sciences · 被引 28)
• An immunity and pyroptosis gene-pair signature predicts overall survival in acute myeloid leukemia (2022 · Leukemia · 被引 21)
• Integrated Network Pharmacology, Machine Learning and Experimental Validation to Identify the Key Targets and Compounds of TiaoShenGongJian for the Treatment of Breast Cancer (2025 · OncoTargets and Therapy · 被引 15)
• Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy (2024 · Cell Communication and Signaling · 被引 13)